AstraZeneca (AZN)

11,452.00p

17:00 24/03/25

  • -1.34% -156.00p
  • Today's Low & High
  • 11,334.00 / 11,632.00
  • Open / Previous Close
  • 11,608.00 / 11,452.00
  • 52-week range
  • 9.25% 970.00p
  • Volume
  • 965,999
  • Market Cap(billion)
  • £177.58b

KEY FINANCIALS

  Latest Forecast
Div Yield 2.1% 2.3%
Div Cover 2.6 2.7
Op Mrgn 18.5% 31.3%
ROCE 60.7%  
  Latest Forecast
P/E 18.0 0.0
PEG 1.4 1.2
Price / Revenue 4.2 3.2
Price / Book value 5.6  
  Latest Forecast
Revenue 18.0% 3.7%
PBT 26.0% n/a
EPS 13.1% -1.4%
DPS 6.9% -0.3%

KEY FUNDAMENTALS

Year Ending Revenue
($m)		 Pre-tax
($m)		 EPS P/E PEG EPS Growth Div Yield
2020-12-31 26,617.00 3,916.00 $2.44 41.0 0.3 137% $2.80 2.8%
2021-12-31 37,417.00 -265.00 $0.08 1,467.0 -15.2 -97% $2.87 2.4%
2022-12-31 44,351.00 2,501.00 $2.12 64.0 0.0 2,550% $2.90 2.1%
2023-12-31 45,811.00 6,899.00 $7.26 18.6 0.1 242% $2.90 2.1%
2024-12-31 54,073.00 8,691.00 $8.21 16.0 1.2 13% $3.10 2.4%

Latest Webfg News

AstraZeneca spending $2.5bn on new R&D centre, biotech deals in China Sharecast News 21 Mar
AstraZeneca buys biotech firm Esobiotec for up to $1bn Sharecast News 17 Mar
AstraZeneca hails trial results for imfinzi on gastric cancer Sharecast News 07 Mar

Regulatory News

AZN invests $2.5bn in Beijing R&D & manufacturing 21-Mar-25 10:58
Eneboparatide Phase III trial met primary endpoint 17-Mar-25 22:56
Imfinzi approved in EU for limited-stage SCLC 17-Mar-25 22:56
AstraZeneca to acquire EsoBiotec 17-Mar-25 22:56
Holding(s) in Company 12-Mar-25 18:00